| Lastest Insider Transactions Of ARROWHEAD PHARMACEUTICALS, INC. ( ARWR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-11-05 | Option Exercise | 12,649 | 5.19 | 65,648 | 2019-11-07 18:45:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-11-01 | Sell | 37,884 | 40.85 | 1,547,378 | 2019-11-01 19:32:19 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-11-01 | Option Exercise | 37,884 | 7.75 | 293,601 | 2019-11-01 19:32:19 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2019-10-10 | Sell | 56,325 | 31.83 | 1,792,825 | 2019-10-11 19:31:20 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2019-10-10 | Option Exercise | 56,325 | 5.20 | 292,890 | 2019-10-11 19:31:20 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2019-09-25 | Sell | 20,000 | 28.25 | 565,000 | 2019-09-27 21:16:03 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2019-09-20 | Sell | 112,650 | 28.54 | 3,215,055 | 2019-09-24 21:12:02 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2019-09-20 | Option Exercise | 112,650 | 5.10 | 574,515 | 2019-09-24 21:12:02 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2019-09-09 | Sell | 185,000 | 29.41 | 5,440,000 | 2019-09-11 20:09:04 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Directior | 2019-06-26 | Sell | 17,756 | 27.61 | 490,243 | 2019-06-28 19:19:15 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-05-31 | Option Exercise | 35,000 | 4.94 | 172,800 | 2019-06-03 18:12:16 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | 2019-05-28 | Sell | 30,000 | 24.88 | 746,400 | 2019-05-29 19:01:45 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2019-05-24 | Option Exercise | 49,448 | 2.13 | 105,110 | 2019-05-29 18:57:38 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-05-21 | Sell | 27,071 | 22.00 | 595,562 | 2019-05-22 17:44:26 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2019-04-03 | Sell | 50,000 | 19.30 | 965,000 | 2019-04-05 18:57:22 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-03-01 | Sell | 42,500 | 19.99 | 849,575 | 2019-03-01 20:42:49 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-03-01 | Option Exercise | 42,500 | 2.01 | 85,425 | 2019-03-01 20:42:49 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-25 | Sell | 42,500 | 18.98 | 806,650 | 2019-02-27 19:08:42 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-25 | Option Exercise | 42,500 | 2.01 | 85,425 | 2019-02-27 19:08:42 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-02-19 | Sell | 8,000 | 18.00 | 144,000 | 2019-02-20 20:12:33 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-02-19 | Option Exercise | 8,000 | 5.20 | 41,600 | 2019-02-20 20:12:33 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-15 | Sell | 68,750 | 17.86 | 1,227,988 | 2019-02-20 20:09:46 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-15 | Option Exercise | 42,500 | 2.01 | 85,425 | 2019-02-20 20:09:46 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-08 | Sell | 242,834 | 16.04 | 3,894,247 | 2019-02-12 20:58:59 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-08 | Option Exercise | 65,834 | 2.23 | 146,560 | 2019-02-12 20:58:59 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-05 | Sell | 22,500 | 14.48 | 325,800 | 2019-02-07 20:35:46 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-02-01 | Sell | 28,500 | 13.85 | 394,725 | 2019-02-01 19:51:49 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-01-22 | Sell | 169,500 | 13.54 | 2,295,805 | 2019-01-24 20:53:24 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2019-01-22 | Sell | 3,000 | 13.58 | 40,740 | 2019-01-24 20:46:05 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | 2019-01-18 | Sell | 72,000 | 14.43 | 1,038,960 | 2019-01-18 19:02:01 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-01-17 | Sell | 81,875 | 14.55 | 1,191,281 | 2019-01-18 19:00:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Li Zhen | Snr. VP, Chem and Non-Clin Dev | 2019-01-14 | Sell | 40,500 | 14.34 | 580,770 | 2019-01-16 20:24:20 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-01-14 | Sell | 42,666 | 14.40 | 614,390 | 2019-01-16 20:18:56 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-01-14 | Option Exercise | 12,666 | 2.90 | 36,765 | 2019-01-16 20:18:56 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2019-01-11 | Sell | 8,500 | 14.77 | 125,545 | 2019-01-11 18:15:19 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2019-01-01 | Sell | 8,333 | 11.98 | 99,829 | 2019-01-03 19:55:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN BRUCE D | Chief Operating Officer | 2019-01-01 | Sell | 20,000 | 11.98 | 239,600 | 2019-01-03 19:53:29 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2018-12-27 | Sell | 3,000 | 12.00 | 36,000 | 2018-12-28 17:20:56 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2018-12-19 | Sell | 90,000 | 13.92 | 1,252,800 | 2018-12-21 17:15:08 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2018-12-12 | Sell | 90,000 | 14.07 | 1,266,300 | 2018-12-14 17:18:07 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2018-11-23 | Sell | 3,000 | 12.74 | 38,220 | 2018-11-26 21:09:58 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2018-11-09 | Sell | 81,500 | 14.39 | 1,172,705 | 2018-11-09 19:01:21 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Leone Peter Brian | VP, Strategic Bus. Initiatives | 2018-10-19 | Sell | 131,137 | 13.49 | 1,769,038 | 2018-10-23 19:59:55 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Leone Peter Brian | VP, Strategic Bus. Initiatives | 2018-10-19 | Option Exercise | 131,137 | 6.20 | 812,512 | 2018-10-23 19:59:55 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2018-09-06 | Sell | 45,000 | 19.34 | 870,200 | 2018-09-10 18:32:44 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2018-09-06 | Option Exercise | 45,000 | 3.57 | 160,500 | 2018-09-10 18:32:44 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2018-08-31 | Sell | 164,834 | 14.45 | 2,381,851 | 2018-09-05 16:23:16 |
